Friedrich Miescher Institute for Biomedical Research, Maulbeerstrasse 66, CH-4058 Basel, Switzerland
Received 29 June 2005/ Returned for modification 8 August 2005/ Accepted 27 September 2005
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Genetic evidence suggests that Ste20 (Sterile)-like protein kinases function as upstream kinases of the NDR family. For example, one of the Saccharomyces cerevisiae Ste20-like kinases, Cdc15p, phosphorylates Dbf2p (28), and the Schizosaccharomyces pombe Ste20-like kinase Pak1p/Shk1p genetically interacts with Orb6p (49). Furthermore, the Ste20-like kinase Kic1p functionally interacts with Cbk1p, the closest relative of NDR from Saccharomyces cerevisiae (33), and the Drosophila melanogaster Ste20-like kinase HIPPO phosphorylates WARTS/LATS kinase (16, 20, 34, 45, 51). The closest mammalian homologues of Kic1p and Hippo are the mammalian Ste20-like protein kinases MST1/KRS1, MST2/KRS2, MST3, MST4/MASK, and SOK/YSK (29), which are involved in the regulation of cell morphology, proliferation, and apoptosis (7, 9, 22, 25, 38). This group of kinases contains an N-terminal kinase domain as well as an autoinhibitory C-terminal regulatory domain. Their activities are regulated by phosphorylation and proteolytic cleavage by caspases in response to stress and apoptotic stimuli (8, 19, 23, 37). Phosphorylation of MST1, for example, increases its activity severalfold and influences its subcellular localization (23). Further, the kinase-dead mutants of MST kinases are known to be inhibitors of MST kinase function in vivo (46).
There is evidence that several MST kinases promote apoptosis in response to stress stimuli and caspase activation. MST1, for example, can induce apoptosis and nuclear condensation in BJAB, 293T, and COS-1 cells (15, 46, 47), and MST1 activity correlates with eosinophil apoptosis (10). Expression of MST3 in HEK293 cells leads to DNA fragmentation and apoptosis (19). YSK1 is activated at initial stages of necrotic cell death (36). In contrast, MST4 regulates cell growth and proliferation in HeLa and Phoenix cells (25). MST4 and YSK1 are localized to the Golgi apparatus, and the latter kinase has been shown to be involved in processes such as cell migration, presumably by linking protein transport events with cellular processes such as cell adhesion or polarization of the cytoskeleton (38).
Our recent work revealed that recruitment of the MOB/NDR complex to the plasma membrane results in phosphorylation on Ser281 and Thr444 and activation of the kinase (17). To clarify and elucidate the role of Ste20-like kinases in regulating the activity of the NDR kinases, we performed in vitro and in vivo experiments with MST3, the closest relative of Kic1p from humans. We provide evidence that MST3 can function as an NDR upstream kinase by phosphorylating the hydrophobic motif and, thus, stimulating kinase activity.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Antibodies.
Anti-P-Ser-282 and anti-P-Thr-442 antibodies were described previously (42). 12CA5 (hemagglutinin [HA]) and 9E10 (myc) monoclonal antibody hybridoma supernatants were used for detection of HA-NDR, HA-MST3, and myc-MST3 variants. Anti-glutathione S-transferase (anti-GST) antibodies (G7781) were purchased from Sigma. Polyclonal anti-HA Y11 antibodies were purchased from Santa Cruz. Anti-MST3 antibodies were purchased from BD Biosciences. Anti-NDR-NT peptide antibody was raised against the synthetic peptide DEEKRLRRSAHARKETEFLRLKRTRLGL, corresponding to amino acids 60 to 86 of NDR2, as described previously (17), and a rat monoclonal anti-
-tubulin (YL1/2)-producing hybridoma cell line was obtained from ATCC.
Plasmids. DNA constructs used for transfection were purified from Escherichia coli XL1 Blue using a Qiafilter Maxiprep kit (QIAGEN) according to the manufacturer's protocol. All DNA constructs were verified by DNA sequencing using an ABI PRISM 3700 DNA analyzer (Applied Biosystems) and custom-synthesized primers. Mammalian expression vector pCMV5-encoding HA-tagged NDR2, HA-MST3, and HA-MST3KR were described previously (19, 42). myc-C1-MOB1A was described previously (17). Bacterial expression constructs for pSHP-NDR2 wild type and mutants and pGEX-2T-MOB1A were described previously (3). BamHI-flanked MST3 cDNA constructs were obtained by deleting the internal BamHI site using the QuikChange site-directed mutagenesis protocol (Stratagene) and the appropriate primers (primer sequences are available upon request) and subsequent amplification using primers 5'-CGCGGATCCATGGCTCAC-TCCCCGGTG-3' and 5'-CGCGGATCCAAAGGAATTTCAGTGGGATG-3'. The resulting PCR product was subcloned with BamHI-BamHI into pcDNA3.0-myc (KpnI-MEQKLISEEDL-BamHI), pEGFP-C1, and pEBG2T.
A 16-amino-acid copolymer of glutamic acid and glycine was added to the N terminus of MST3 using PCR. The linker-MST3 fragment was amplified using primers 5'-AACTGCAGGAAGGTGAGGGCGAAGGTGAGGGCGAAGGTGAGGGCGAAGGTGAGGGCATGGCTCACTCCCCG-3' and 5'-GCTCTAGATCAGTGGGATGAAGTTCC-3'. The PstI-XbaI fragment was subcloned into pCMV5. To create a pCMV5-HA-NDR2-MST3 fusion construct, HA-tagged NDR2 was amplified using primers 5'-CTTCCAAGCGCTTAGTCGACATGGCTTACCCATACGATGTTCCAGATTACGCTTCGGCAATGACGGCAGGGACTACAACAACC-3' and 5'-AACTGCAGTAACTTCCCAGCTTTCATGTAGG-3' and subcloned as a HindIII-PstI fragment into pCMV5 (linker-MST3). The myc-C1-MOB1A was described previously (17).
The pTER-shMST3 vectors were cloned using the HindIII-BglII-digested pTER vector (48) and the oligonucleotides 5'-GATCCCGGCATTGACAATCGGACTCTTCAAGAGAGAGTCCGATTGTCAATGCCTTTTTGGAAA-3' and 5'-AGCTTTTCCAAAAAGGCATTGACAATCGGACTCTCTCTTGAAGAGTCCGATTGTCAATGCCGG-3' for shMST3.
Western blotting and immunoprecipitation.
Cell lysis buffer (immunoprecipitation [IP] buffer) contained 20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 10% glycerol, 1 mM Na3VO4, 20 mM ß-glycerol phosphate, 1 µM microcystin, 50 mM NaF, 0.5 mM phenylmethylsulfonyl fluoride, 4 µM leupeptin, and 1 mM benzamidine. To detect HA-NDR, SHP-NDR, HA-MST3, and myc-MST3, samples were resolved by 10 or 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene difluoride membranes. Membranes were blocked in TBST (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.05% Tween 20) containing 5% skimmed milk powder and then probed overnight at 4°C with the following antibodies: anti-GST, 12CA5 anti-HA, 9E10 anti-myc, and anti-Thr-442P; or anti-Ser-282-P, anti-NDR-NT, and anti-MST3; and anti-
-tubulin YL1/2. Bound antibodies were detected with horseradish peroxidase-linked secondary antibodies and enhanced chemiluminescence. For immunoprecipitations, HEK293F or COS-7 cells transfected with HA-MST3 wild type, HA-MST3-KR, or HA-NDR2 variants were harvested as described above. Cell lysates (0.5 mg protein) were precleared with protein A- or G-Sepharose and mixed subsequently for 3 h at 4°C with anti-HA 12CA5 antibody prebound to protein A-Sepharose. The beads were then washed twice with IP buffer, once with IP buffer containing 1 M NaCl, once again with IP buffer, and twice with 20 mM Tris-HCl, pH 7.5, containing 4 µM leupeptin and 1 mM benzamidine. Samples were then subjected to kinase assays and/or were resolved by 10% SDS-PAGE. HA-MST3, HA-MST3KR, and HA-NDR2 variants were detected by Western blotting using anti-HA 12CA5 monoclonal antibodies.
Bacterial expression of human GST-fused MOB1A and human SHP-fused NDR2. XL-1 Blue E. coli was transformed with the pGEX-2T-MOB1A plasmid. Mid-logarithmic-phase cells were induced with 0.1 mM isopropyl ß-D-thiogalactopyranoside overnight at 20°C. Bacterial lysis buffers contained 20 mM Tris-HCl, pH 8.5, 10 mM 2-mercaptoethanol, 1% NP-40, 0.5 M NaCl, and Complete proteinase inhibitor cocktail (Roche). Bacteria were disrupted using a French press in the presence of 1 mg/ml lysozyme and protease inhibitors, and the fusion proteins were purified on glutathione-Sepharose. SHP-NDR2 wild-type and mutant plasmids were transformed into XL-1 Blue E. coli cells as described for GST-hMOB1A, and protein was purified on Ni-nitrilotriacetic acid-Sepharose.
NDR protein kinase assays.
Transfected COS-7 cells were washed once with ice-cold phosphate-buffered saline (PBS) and harvested 24 or 48 h after transfection in 1 ml of ice-cold phosphate-buffered saline containing 1 mM Na3VO4 and 20 mM ß-glycerol phosphate before lysis in 500 µl IP buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 10% glycerol, 1 mM Na3VO4, 20 mM ß-glycerol phosphate, 1 µM microcystin, 50 mM NaF, 0.5 mM phenylmethylsulfonyl fluoride, 4 µM leupeptin, and 1 mM benzamidine). Lysates were centrifuged at 20,000 x g for 20 min, and duplicate aliquots (250 µg) of the supernatant were precleared with protein A-Sepharose for 60 min and mixed for 3 h at 4°C with anti-HA 12CA5 antibody prebound to protein A-Sepharose. The beads were then washed twice with IP buffer, once for 10 min with IP buffer containing 1 M NaCl, again for 10 min with IP buffer, and twice with 20 mM Tris-HCl, pH 7.5, containing 4 µM leupeptin and 1 mM benzamidine. Thereafter, the beads were resuspended in 30 µl of buffer containing 20 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 1 mM dithiothreitol, 100 µM [
-32P]ATP (
1,000 cpm/pmol), 1 µM cyclic AMP (cAMP)-dependent protein kinase inhibitor peptide, 4 µM leupeptin, 1 mM benzamidine, 1 µM microcystin, and 1 mM NDR substrate peptide (KKRNRRLSVA). After a 60-min incubation at 30°C, the reaction mixtures were processed as previously described (44).
Purified recombinant SHP-NDR2 wild type and mutants (1 µg) were preautophosphorylated or prephosphorylated for 60 min in the presence of HA-MST3 or HA-MST3KR (immunoprecipitated from 500 µg of lysates of untreated and okadaic acid [OA]-treated HEK293F cells) in 30 µl of buffer containing 20 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 1 mM dithiothreitol, 100 µM ATP, 1 µM cAMP-dependent protein kinase inhibitor peptide, 4 µM leupeptin, 1 mM benzamidine, and 1 µM microcystin. Aliquots of 10 µl of the supernatant containing SHP-NDR or mutants were removed. One aliquot was assayed for activity using our standard conditions (reaction mixture of 30 µl containing 20 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 1 mM dithiothreitol, 100 µM [
-32P]ATP [
1,000 cpm/pmol], 1 µM cAMP-dependent protein kinase inhibitor peptide, 4 µM leupeptin, 1 mM benzamidine, 1 µM microcystin, and 1 mM NDR substrate peptide). After incubation for 30 min at 30°C, the reaction mixtures were processed and kinase activity was determined as described for the HA-NDR kinase assay. The second aliquot was resolved by 10% SDS-PAGE and analyzed for phosphorylation and amount of protein using anti-T-442-P and anti-S-282-P antibodies by Western blotting and Coomassie staining, respectively.
Time course analyses of hydrophobic motif phosphorylation and activity of SHP-NDR2 variants (1 µg) in the presence or absence of GST-MOB1A and in the presence or absence of GST-MST3 from untreated or OA-treated HEK293F cells were performed under our kinase assay standard conditions, as described above. Kinase assays were stopped after 0, 15, 30, 60, 90, and 120 min by adding 3 µl of 0.5 M EDTA. The reaction mixtures were processed, and kinase activity was determined as described for the HA-NDR kinase assay. Phosphorylation of NDR was detected by Western blotting, as described above.
Localization of MST3 and NDR2. Exponentially growing cells were plated on coverslips and transfected the next day with the indicated constructs using Fugene 6 (Roche) as described by the manufacturer. After the 24-h transfection, cells were washed with PBS and fixed in 3% paraformaldehyde-2% sucrose in PBS at pH 7.4 for 10 min at 37°C. They were then permeabilized using 0.2% Triton X-100 in PBS for 2 min at room temperature. All subsequent steps were carried out at room temperature. Coverslips were rinsed twice with PBS and incubated for 1 h with anti-HA Y11 (Santa Cruz) and anti-myc 9E10 diluted in PBS containing 1% bovine serum albumin-1% goat serum. After three 1-min washes in PBS, goat anti-rabbit antibody-fluorescein isothiocyanate (FITC; Sigma) and goat anti-mouse antibody-Texas Red (Sigma) were used as secondary antibodies. DNA was counterstained with 4 µg/ml Hoechst (Sigma). Coverslips were then inverted into 5 µl Vectashield medium (Vector Lab). Images were obtained with an Eclipse E800 microscope using a CoolPix950 digital camera (Nikon) and processed using Adobe Photoshop 6.0 (Adobe Systems Inc.). Only cells with intact nuclei were included in the statistical evaluation. Cells expressing GFP-MST3 were fixed and then stained for DNA without permeabilization and antibody incubation steps.
Cell fractionation. To separate cytosolic and membrane-associated proteins, cells were subjected to S100/P100 fractionation as follows: cells were collected in PBS and incubated for 20 min at 4°C in S100/P100 buffer (20 mM Tris, 150 mM NaCl, 2.5 mM EDTA, 1 mM EGTA, 1 mM benzamidine, 4 µM leupeptin, 0.5 mM PMSF, 1 µM microcystin, and 1 mM dithiothreitol at pH 7.5) and homogenized by passage through a 26-gauge needle (Beckton Dickinson), and nuclei were removed by centrifugation for 2 min at 1,000 x g at 4°C. The supernatant was then centrifuged at 100,000 x g for 60 min at 4°C. Equal amounts of protein from the supernatant (S100; cytoplasmic fraction) and the pellet (P100; membrane fraction) were analyzed by SDS-PAGE followed by immunoblotting.
| RESULTS |
|---|
|
|
|---|
Activation and hydrophobic motif phosphorylation of NDR protein kinase by MST3. We expressed HA-MST3wt and the kinase-dead HA-MST3KR in HEK293F cells and treated them with 1 µM OA for 1 h (MST3+; MST3KR+) or solvent control (MST3; MST3KR). The HA-tagged MST3 kinase variants were immunoprecipitated with the anti-HA 12CA5 monoclonal antibody and incubated with SHP-NDR2 and catalytically inactive SHP-NDR2KD for 1 h at 30°C. Subsequently, the beads with bound MST3 were removed and the supernatants containing the SHP-NDR proteins were analyzed for activity and phosphorylation status using anti-Ser282-P and anti-Thr442-P specific phospho-antibodies. Kinase assays were carried out for 30 min with the NDR substrate peptide (30). (We previously established that activated MST3 does not significantly phosphorylate the NDR substrate peptide.)
Significantly, preincubation with nonstimulated MST3 only led to a twofold activation of NDR2, while preincubation with OA-activated MST3 resulted in a 10-fold increase in NDR2 activity, suggesting that a certain population of MST3 is active in nonstimulated cells. This result reflected an increase in phosphorylation of both the activation segment phosphorylation site Ser282 and the hydrophobic motif phosphorylation site Thr442 (Fig. 1A). Analysis of the phospho-status of the kinase-dead NDR2 revealed that MST3 phosphorylates NDR2 on Thr442, but not on Ser282 (Fig. 1B). Results from the same experiments performed with the kinase-dead MST3KR confirmed that phosphorylation as well as activation of NDR2 depend on MST3 activity. Significantly, our results also show that OA treatment of HEK293F cells promotes the activation of MST3 similar to that previously found for NDR (32). To have a more robust effect on NDR activation, we used activated MST3 (isolated from OA-treated cells) in the following in vitro experiments.
|
|
NDR hydrophobic motif site phosphorylation by MST3 in vivo. To examine the role of MST3 in NDR activation in vivo, we performed cotransfection experiments with HA-NDR2, myc-MST3, and myc-MST3KR using COS-7 cells. Analysis of the phosphorylation of NDR revealed a small but significant increase in Thr442 phosphorylation in cells expressing MST3 and NDR2 compared with cells expressing NDR2 alone (Fig. 3A). The extent of NDR2 phosphorylation was less than that obtained after OA stimulation, as shown with anti-P-Thr442 (Fig. 3A). Cells expressing the kinase-dead variant MST3KR and NDR2 showed a reduction in Thr442 phosphorylation (Fig. 3A). Inhibition of Thr442 phosphorylation by the kinase-dead MST3KR suggests that the mutant protein acts as an inhibitor of Thr442 phosphorylation mediated by endogenous MST3 (see below). Evidence in support of this hypothesis comes from the inhibition of OA-induced phosphorylation of the NDR2 hydrophobic motif by cotransfection with MST3KR, which resulted in 70% lower NDR activity and Thr442 phosphorylation (Fig 3B). Ser282 phosphorylation was largely unchanged (Fig. 3B). This suggests that MST3KR acts as an inhibitor of Thr442 phosphorylation. The reduced phosphorylation was also reflected by decreased NDR activity.
|
|
(amino acids 26 to 126) results in an increase of hydrophobic motif phosphorylation and NDR activity (17). To further establish the in vivo role of MST3 in regulating endogenous NDR, we transfected HEK293F cells with a myc-C1-MOB1A chimera and different MST3 constructs designed to manipulate the levels of the upstream kinase. The cells were stimulated, after 24 h of starvation, with 100 ng/ml TPA or solvent control for 15 min, and hydrophobic motif phosphorylation of endogenous NDR was determined using anti-P-Thr442 antibodies (Fig. 5A). TPA treatment promoted recruitment of endogenous NDR to the membrane and promoted phosphorylation. Overexpression of HA-MST3 increased the phosphorylation of Thr442 in unstimulated and stimulated cells. Knockdown of MST3 protein (Fig. 5A) led to almost complete inhibition of NDR2 phosphorylation. Furthermore, our results show that MST3KR also inhibits phosphorylation of endogenous MST3. The results show a clear correlation between MST3 levels and hydrophobic motif phosphorylation of NDR following TPA-induced membrane recruitment of C1-tagged-MOB1A, indicating that MST3 is indeed a physiological regulator of NDR in vivo.
|
50%) in samples cotransfected with pTER-shMST3. The activation was only partially inhibited, because we were unable to achieve full knockdown of MST3. In agreement with our results obtained with endogenous NDR, Thr442 phosphorylation of HA-NDR2 showed a clear dependence on MST3, indicating that membrane recruitment of the NDR/MOB complex is crucial for NDR activation and phosphorylation by MST3. Activation and phosphorylation of MOB1-binding-deficient NDR2. To obtain further insights into the role of MOB1 in the activation process of NDR, we examined its activation and phosphorylation following OA treatment using the MOB1-binding-deficient mutant NDR2Y32A (3). Despite the fact that NDR2Y32A was phosphorylated on Thr442 to the same extent as wild-type NDR2, activation of the kinase was only 2- to 3-fold, compared with 30-fold for the wild-type control (Fig. 6). This result shows that MOB1 binding is required for full activation and correlates well with the results obtained in vitro, arguing that MST3 functions as an upstream kinase and that MOB1 releases autoinhibition.
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
|
Targeting of NDR to the membrane provides evidence for the importance of subcellular localization in the activation mechanism. Membrane targeting of NDR results in increased hydrophobic motif phosphorylation as well as activation of the kinase (17), which is dependent on the MST3 activity in HEK293F cells. However, our results suggest that the interaction of NDR2 and MST3 is likely to be transient. Recruitment of NDR to the membrane via myc-C1-MOB1 resulted in phosphorylation of the kinase. MST3 was not corecruited, but a significant portion of MST3 was already associated with the membrane. This suggests that the interaction of MST3 with NDR2 is not stable, similar to the interaction reported between MST1/2 and the NDR relative LATS1/Warts (5, 21). However, it has also been reported for other kinase substrate interactions that the affinity for their substrate is weak (4) and below the detection limit of immunoprecipitation (35). We propose that membrane recruitment of NDR is an essential part of the NDR activation mechanism and that the phosphorylation of NDR by MST3 occurs at the membrane. However, future experiments will have to address the question of what signals are responsible for membrane recruitment of the NDR/MOB complex in vivo. It is also possible that NDR is targeted to the membrane to phosphorylate proteins specifically localized to this region of the cell.
MST3 purified from OA-treated cells showed significantly more activity in the cell-free assays compared with the enzyme isolated from untreated cells. This suggests that MST3 activity is regulated by phosphorylation that can be initiated by treating cells with the PP2A inhibitor OA. The mechanism of MST3 regulation remains to be fully elucidated, but the available results provide an explanation for the dramatic effects of OA on NDR activity. Previously, we found that MOB1A binding to NDR is facilitated apparently by treatment of cells with OA (3). We conclude that a PP2A-like phosphatase negatively regulates both kinases and MOB1A function; the key issue in the future will be to understand the regulation of the phosphatase in this signaling network.
Significantly, we provide the first evidence that cleavage of MST3 can, at least partially, be induced by NDR in a regulatory feedback loop. NDR2 overexpression can induce cleavage of MST3 and MST3KR, whereas the kinase-dead NDR2K119A had no effect on cleavage. Interestingly, caspases 3, 7, 8, and 9 are processed in cancer cells infected with an adenovirus expressing the human LATS2 kinase, a close relative of NDR. Further, it was shown that the Drosophila Warts kinase together with the Ste20-like kinase Hippo regulate the levels of DIAP1 (Drosophila inhibitor of apoptosis) (16, 20, 34, 45, 51). Mammalian IAP proteins are known inhibitors of caspase activation (26, 41) but also play a role in signal transduction and cell cycle regulation (1, 39).
Genetic studies with yeast, worms, and flies have shown that many of the components of the NDR signaling pathway are highly conserved, such as the scaffold protein Pag1p (mor2p, sax-2, FURRY), the Ste20-like kinase Kic1p (gck-1), the adapter protein Hym1p (dMO25), the activator protein Mob2p (dMOB proteins), and the transcription factor Ace2p (Krueppel-like transcription factor) (43). Based on the conserved protein components, the NDR signaling pathway is more closely related to the signaling pathway established for Cbk1p than to Dbf2p (which appears to be more closely related to LATS). Our work on the human NDR suggests that conservation is also maintained with the mammalian counterparts of some of these proteins. However, despite the high conservation of the proteins, the processes they regulate are likely to differ due to species variation between yeast (e.g., regulation of chitinase expression) and higher organisms. Further work is required to fully elucidate the functions of these different proteins. However, the involvement of the yeast NDR kinases in the MEN (mitotic exit network) and RAM (regulation of Ace2p transcription and morphogenesis) network (43) raises the possibility of a cell-intrinsic regulation of NDR activity, which might explain why all attempts so far (growth hormones, oxidative stress, UV, ceramide, fluoride, or serum) to identify a ligand/hormone or endogenous stimuli have failed (2).
Significant insights into the physiological roles of NDR kinases have been obtained using yeast, worm, and fly genetic screens. Early studies from yeast found that NDR family kinases play a significant role in the regulation of actin and tubulin cytoskeletal organization during polarized growth and cytokinesis and are central components of the mitotic exit network (43). Worm NDR regulates cell spreading and neurite outgrowth of chemosensory neurons (53). The fly NDR is reported to be important for the integrity of cellular outgrowths, such as wing hairs and bristles (14). Recently, it was shown that NDR kinase activity plays an important role in the regulation of dendritic branching and tiling in worms and flies (12, 13). These results predict that mammalian NDR also plays a significant role in the control of cell division and morphogenesis. Identification of NDR-specific substrates will help to define the physiological roles of this conserved signaling pathway.
| ACKNOWLEDGMENTS |
|---|
M.R.S. is supported by the Krebsliga beider Basel, R.T. is supported by the Krebsliga Schweiz (KLS 01342-02-2003), and A.H. is supported by the Roche Research Foundation. The Friedrich Miescher Institute is part of the Novartis Research Foundation.
| FOOTNOTES |
|---|
Supplemental material for this article may be found at http://mcb.asm.org/. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Bichsel, S. J. 2000. Regulation of NDR, a nuclear serine/threonine kinase. Diploma thesis. University of Basel, Basel, Switzerland.
3. Bichsel, S. J., R. Tamaskovic, M. R. Stegert, and B. A. Hemmings. 2004. Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein. J. Biol. Chem. 279:35228-35235.
4. Borders, C. L., M. J. Snider, R. Wolfenden, and P. L. Edmiston. 2002. Determination of the affinity of each component of a quaternary transition state analogue complex of creatine kinase. Biochemistry 41:6995-7000.[CrossRef][Medline]
5. Chan, E. H., M. Nousiainen, R. B. Chalamalasetty, A. Schafer, E. A. Nigg, and H. H. Sillje. 2005. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 24:2076-2086.[CrossRef][Medline]
6. Colman-Lerner, A., T. E. Chin, and R. Brent. 2001. Yeast Cbk1 and Mob2 activate daughter-specific genetic programs to induce asymmetric cell fates. Cell 107:739-750.[CrossRef][Medline]
7. Dan, I., S. E. Ong, N. M. Watanabe, B. Blagoev, M. M. Nielsen, E. Kajikawa, T. Z. Kristiansen, M. Mann, and A. Pandey. 2002. Cloning of MASK, a novel member of the mammalian germinal center kinase III subfamily, with apoptosis-inducing properties. J. Biol. Chem. 277:5929-5939.
8. Deng, Y., A. Pang, and J. H. Wang. 2003. Regulation of mammalian STE20-like kinase 2 (MST2) by protein phosphorylation/dephosphorylation and proteolysis. J. Biol. Chem. 278:11760-11767.
9. De Souza, P. M., and M. A. Lindsay. 2004. Mammalian Sterile 20-like kinase 1 and the regulation of apoptosis. Biochem. Soc. Trans. 32:485-488.[CrossRef][Medline]
10. De Souza, P. M., H. Kankaanranta, A. Michael, P. J. Barnes, M. A. Giembycz, and M. A. Lindsay. 2002. Caspase-catalyzed cleavage and activation of Mst1 correlates with eosinophil but not neutrophil apoptosis. Blood 99:3432-3438.
11. Devroe, E., H. Erdjument-Bromage, P. Tempst, and P. A. Silver. 2004. Human Mob proteins regulate the NDR1 and NDR2 serine-threonine kinases. J. Biol. Chem. 279:24444-24451.
12. Emoto, K., Y. He, B. Ye, W. B. Grueber, P. N. Adler, L. Y. Jan, and Y. N. Jan. 2004. Control of dendritic branching and tiling by the Tricornered-kinase/Furry signaling pathway in Drosophila sensory neurons. Cell 119:245-256.[CrossRef][Medline]
13. Gallegos, M. E., and C. I. Bargmann. 2004. Mechanosensory neurite termination and tiling depend on SAX-2 and the SAX-1 kinase. Neuron 44:239-249.[CrossRef][Medline]
14. Geng, W., B. He, M. Wang, and P. N. Adler. 2000. The tricornered gene, which is required for the integrity of epidermal cell extensions, encodes the Drosophila nuclear DBF2-related kinase. Genetics 156:1817-1828.
15. Graves, J. D., K. E. Draves, Y. Gotoh, E. G. Krebs, and E. A. Clark. 2001. Both phosphorylation and caspase-mediated cleavage contribute to regulation of the Ste20-like protein kinase Mst1 during CD95/Fas-induced apoptosis. J. Biol. Chem. 276:14909-14915.
16. Harvey, K. F., C. M. Pfleger, and I. K. Hariharan. 2003. The Drosophila Mst ortholog, Hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 114:457-467.[CrossRef][Medline]
17. Hergovich, A., S. J. Bichsel, and B. A. Hemmings. 2005. Human NDR kinases are rapidly activated by MOB proteins through recruitment to the plasma membrane. Mol. Cell. Biol. 25:8259-8272.
18. Hou, M. C., D. A. Guertin, and D. Mc Collum. 2004. Initiation of cytokinesis is controlled through multiple modes of regulation of the Sid2p-Mob1p kinase complex. Mol. Cell. Biol. 24:3262-3276.
19. Huang, C. Y., Y. M. Wu, C. Y. Hsu, W. S. Lee, M. D. Lai, T. J. Lu, C. L. Huang, T. H. Leu, H. M. Shih, H. I. Fang, D. R. Robinson, H. J. Kung, and C. J. Yuan. 2002. Caspase activation of mammalian sterile 20-like kinase 3 (Mst3). Nuclear translocation and induction of apoptosis. J. Biol. Chem. 277:34367-34374.
20. Jia, J., W. Zhang, B. Wang, R. Trinko, and J. Jiang. 2003. The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev. 17:2514-2519.
21. Lai, Z. C., X. Wei, T. Shimizu, E. Ramos, M. Rohrbaugh, N. Nikolaides, L. L. Ho, and Y. Li. 2005. Control of cell proliferation and apoptosis by Mob as tumor suppressor, Mats. Cell 120:675-685.[CrossRef][Medline]
22. Lee, K. K., T. Ohyama, N. Yajima, S. Tsubuki, and S. Yonehara. 2001. MST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation. J. Biol. Chem. 276:19276-19285.
23. Lee, K. K., and S. Yonehara. 2002. Phosphorylation and dimerization regulate nucleocytoplasmic shuttling of mammalian STE20-like kinase (MST). J. Biol. Chem. 277:12351-12358.
24. Lee, W. S., C. Y. Hsu, P. L. Wang, P. L., C. Y. Huang, C. H. Chang, and C. J. Yuan. 2004. Identification and characterization of the nuclear import and export signals of the mammalian Ste20-like protein kinase 3. FEBS Lett. 572:41-45.[CrossRef][Medline]
25. Lin, J. L., H. C. Chen, H. I. Fang, D. Robinson, H. J. Kung, and H. M. Shih. 2001. MST4, a new Ste20-related kinase that mediates cell growth and transformation via modulating ERK pathway. Oncogene 20:6559-6569.[CrossRef][Medline]
26. Liston, P., W. G. Fong, and R. G. Korneluk. 2003. The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22:8568-8580.[CrossRef][Medline]
27. Lowe, E. D., M. E. Noble, V. T. Skamnaki, N. G. Oikonomakos, D. J. Owen, and L. N. Johnson. 1997. The crystal structure of a phosphorylase kinase peptide substrate complex: kinase substrate recognition. EMBO J. 16:6646-6658.[CrossRef][Medline]
28. Mah, A. S., J. Jang, and R. J. Deshaies. 2001. Protein kinase Cdc15 activates the Dbf2-Mob1 kinase complex. Proc. Natl. Acad. Sci. USA 98:7325-7330.
29. Manning, G., D. B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam. 2002. The protein kinase complement of the human genome. Science 298:1912-1934.
30. Millward, T. A., P. Cron, and B. A. Hemmings. 1995. Molecular cloning and characterization of a conserved nuclear serine (threonine) protein kinase. Proc. Natl. Acad. Sci. USA 92:5022-5026.
31. Millward, T. A., C. W. Heizmann, B. W. Schafer, and B. A. Hemmings. 1998. Calcium regulation of Ndr protein kinase mediated by S100 calcium-binding proteins. EMBO J. 17:5913-5922.[CrossRef][Medline]
32. Millward, T. A., D. Hess, and B. A. Hemmings. 1999. Ndr protein kinase is regulated by phosphorylation on two conserved sequence motifs. J. Biol. Chem. 274:33847-33850.
33. Nelson, B., C. Kurischko, J. Horecka, M. Mody, P. Nair, L. Pratt, A. Zougman, L. D. McBroom, T. R. Hughes, C. Boone, and F. C. Luca. 2003. RAM: a conserved signaling network that regulates Ace2p transcriptional activity and polarized morphogenesis. Mol. Biol. Cell 14:3782-3803.
34. Pantalacci, S., N. Tapon, and P. Leopold. 2003. The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nat. Cell Biol. 5:921-927.[CrossRef][Medline]
35. Piehler, J. 2005. New methodologies for measuring protein interactions in vivo and in vitro. Curr. Opin. Struct. Biol. 15:4-14.[CrossRef][Medline]
36. Pombo, C. M., T. Tsujita, J. Kyriakis, J. V. Bonventre, and T. Force. 1997. Activation of the Ste-20-like oxidant stress response kinase-1 during the initial stages of chemical anoxia-induced necrotic cell death. J. Biol. Chem. 272:29372-29379.
37. Praskova, M., A. Khoklatchev, S. Ortiz-Vega, and J. Avruch. 2004. Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. Biochem. J. 381:453-462.[CrossRef][Medline]
38. Preisinger, C., B. Short, V. De Corte, E. Bruyneel, A. Haas, R. Kopajtich, J. Gettemans, and F. A. Barr. 2004. YSK1 is activated by the Golgi matrix protein GM130 and plays a role in cell migration through its substrate 14-3-3
. J. Cell Biol. 164:1009-1020.
39. Richter, B. W., and C. S. Duckett. 2000. The IAP proteins: caspase inhibitors and beyond. Sci. STKE 2000(44):PE1.[Medline]
40. Robinson, M. J., S. A. Stippec, E. Goldsmith, M. A. White, and M. H. Cobb. 1998. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr. Biol. 8:1141-1150.[CrossRef][Medline]
41. Salvesen, G. S., and J. M. Abrams. 2004. Caspase activationstepping on the gas or releasing the brakes? Lessons from humans and flies. Oncogene 23:2774-2784.[CrossRef][Medline]
42. Stegert, M. R., R. Tamaskovic, S. J. Bichsel, A. Hergovich, and B. A. Hemmings. 2004. Regulation of NDR2 protein kinase by multi-site phosphorylation and the S100B calcium-binding protein. J. Biol. Chem. 279:23806-23812.
43. Tamaskovic, R., S. J. Bichsel, and B. A. Hemmings. 2003. NDR family of AGC kinasesessential regulators of the cell cycle and morphogenesis. FEBS Lett. 546:73-80.[CrossRef][Medline]
44. Tamaskovic, R., S. J. Bichsel, H. Rogniaux, M. R. Stegert, and B. A. Hemmings. 2003. Mechanism of Ca2+-mediated regulation of NDR protein kinase through autophosphorylation and phosphorylation by an upstream kinase. J. Biol. Chem. 278:6710-6718.
45. Udan, R. S., M. Kango-Singh, R. Nolo, C. Tao, and G. Halder. 2003. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat. Cell Biol. 5:914-920.[CrossRef][Medline]
46. Ura, S., N. Masuyama, J. D. Graves, and Y. Gotoh. 2001. Caspase cleavage of MST1 promotes nuclear translocation and chromatin condensation. Proc. Natl. Acad. Sci. USA 98:10148-10153.
47. Ura, S., N. Masuyama, J. D. Graves, and Y. Gotoh. 2001. MST1-JNK promotes apoptosis via caspase-dependent and independent pathways. Genes Cells 6:519-530.[Abstract]
48. van de Wetering, M., I. Oving, V. Muncan, M. T. Pon Fong, H. Brantjes, D. van Leenen, F. C. Holstege, T. R. Brummelkamp, R. Agami, and H. Clevers. 2003. Specific inhibition of gene expression using a stably integrated, inducible small-interfering RNA vector. EMBO Rep. 4:609-615.[CrossRef][Medline]
49. Verde, F., D. J. Wiley, and P. Nurse. 1998. Fission yeast orb6, a ser/thr protein kinase related to mammalian rho kinase and myotonic dystrophy kinase, is required for maintenance of cell polarity and coordinates cell morphogenesis with the cell cycle. Proc. Natl. Acad. Sci. USA 95:7526-7531.
50. Weiss, E. L., C. Kurischko, C. Zhang, K. Shokat, D. G. Drubin, and F. C. Luca. 2002. The Saccharomyces cerevisiae Mob2p-Cbk1p kinase complex promotes polarized growth and acts with the mitotic exit network to facilitate daughter cell-specific localization of Ace2p transcription factor. J. Cell Biol. 158:885-900.
51. Wu, S., J. Huang, J. Dong, and D. Pan. 2003. Hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with Salvador and Warts. Cell 114:445-456.[CrossRef][Medline]
52. Yang, J., P. Cron, V. M. Good, V. Thompson, B. A., Hemmings, and D. Barford. 2002. Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP. Nat. Struct. Biol. 9:940-944.[CrossRef][Medline]
53. Zallen, J. A., E. L. Peckol, D. M. Tobin, and C. I. Bargmann. 2000. Neuronal cell shape and neurite initiation are regulated by the Ndr kinase SAX-1, a member of the Orb6/COT-1/Warts serine/threonine kinase family. Mol. Biol. Cell 11:3177-3190.
This article has been cited by other articles:
| |||||||||||||||||||||||